---
title: "Moleculin Biotech Inc. Held Special Meeting of Stockholders"
description: "Moleculin Biotech Inc. held a Special Meeting of Stockholders on October 16, 2025, where stockholders approved the issuance of up to 64,864,864 shares of common stock related to certain warrants. Howe"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261477503.md"
published_at: "2025-10-16T15:16:41.000Z"
---

# Moleculin Biotech Inc. Held Special Meeting of Stockholders

> Moleculin Biotech Inc. held a Special Meeting of Stockholders on October 16, 2025, where stockholders approved the issuance of up to 64,864,864 shares of common stock related to certain warrants. However, a proposal to change the company’s name to Moleculin Inc. was not approved. The meeting also received approval for a potential adjournment to solicit additional proxies.

Moleculin Biotech Inc. held a Special Meeting of Stockholders on October 16, 2025. Stockholders approved the issuance of up to 64,864,864 shares of common stock upon the exercise of certain warrants issued on August 28, 2025. A proposal to amend the company’s name from Moleculin Biotech, Inc. to Moleculin Inc. was not approved. Approval was given for a potential adjournment of the meeting, if necessary, to solicit additional proxies. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-031123), on October 16, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [MBRX.US - Moleculin Biotech](https://longbridge.com/en/quote/MBRX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Moleculin Biotech Raises $6.8 Million Through Warrant Exercises | Moleculin Biotech Inc. raised $6.8 million through warrant exercises, involving 727,969 shares at $6.63 per share and 31 | [Link](https://longbridge.com/en/news/269236812.md) |
| Moleculin Biotech Inc. Held Special Stockholder Meeting | Moleculin Biotech Inc. held a Special Meeting of Stockholders on February 5, 2026, where stockholders approved the issua | [Link](https://longbridge.com/en/news/275007952.md) |
| Arteris Inc. CEO Charles Janac Reports Sale of Common Shares | Charles K. Janac, CEO of Arteris Inc., reported the sale of common shares as a beneficial owner. The full filing is avai | [Link](https://longbridge.com/en/news/275675466.md) |
| EverCommerce Inc. President Matthew David Feierstein Reports Sale of Common Shares | Matthew David Feierstein, President of EverCommerce Inc., has reported the sale of common shares of the company. The ful | [Link](https://longbridge.com/en/news/275513151.md) |
| FormFactor Inc. Director Thomas St Dennis Sells Common Shares | Thomas St Dennis, Director at FormFactor Inc., has sold common shares of the company. The full filing is available throu | [Link](https://longbridge.com/en/news/275670858.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.